Skip to main content
. 2011 Mar 11;1(4):498–507.

Table 2.

Correlations between clinico-pathologic features and 9p22, FGFR3 and combined FGFR3/9p22 statuses

Combined FGFR3/9p22 status FGFR3 status 9p22 status



mtFGFR3/ROH wtFGFR3/ROH mtFGFR3/LOH wtFGFR3/LOH wt mt ROH LOH
Age:
 <65y 11 14 3 5 19 14 25 8
 >65y 11 8 4 2 10 15 19 6
 p value 0.573 0.185 0.983
Multifocality:
 No 9 11 4 6 17 13 20 10
 Yes 13 11 3 1 12 16 24 4
 p value 0.223 0.293 0.090
Previous BC
 No 9 16 3 5 21 12 25 8
 Yes 13 6 4 2 8 17 19 6
 p value 0.127 0.017 0.983
Smokers :
 No 9 11 3 3 14 12 20 6
 Yes 13 11 4 4 15 17 24 8
 p value 0.941 0.597 0
Adjuvant treatment:
 No 9 3 2 1 4 11 12 3
 Yes 13 19 5 6 25 18 32 11
 p value 0.001 0.036 0.664
Stade :
 pTa 20 11 4 1 12 24 31 5
 pT1 2 11 3 6 17 5 13 9
 p value 0.001 0.001 0.020
Grade:
 G1 10 4 0 0 4 10 14 0
 G2 12 5 5 3 8 17 17 8
 G3 0 13 2 4 17 2 13 6
 p value <0.001 <0.001 0.053
CIS:
 No 21 18 6 6 24 27 39 12
 Yes 1 4 1 1 5 2 5 2
 p value 0.570 0.423 0.710